manilatimes15h
Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes
With the aim to positively impact the health of 2.5 billion people by the end of the decade, GSK prioritises innovation in vaccines and specialty medicines, maximising the increasing opportunities to ...
STAT15h
Risk of aspiration during surgery added to GLP-1 drug labels
Kennedy is well known for his anti-vaccine stances and his support for alternative therapies. He’s openly criticized the FDA ...
Daily7h
GSK RSV vaccine approved in Canada for adults aged 50-59 at increased risk
Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...
Le Lézard24m
ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...
AllAfrica.com9h
Nigeria: New Executive Order - Hope for Nigeria's Health Sector Amid the Economic Challenges
In an exclusive interview with Nigeria Health Watch, Dr Mukhtar outlined the Executive Order's two-year validity, and its transformative provisions. Central to this includes the removal of tariffs, ...
Pharmaceutical Technology4h
Moderna’s mRESVIA vaccine gains Health Canada approval
The approval marks the introduction of the first mRNA RSV vaccine in Canada. Credit: MargJohnsonVA via Shutterstock. Moderna has received Health Canada’s approval for its respiratory syncytial virus ...